Acknowledgements This study was supported by grants from The Natural Science Foundation of China (No.81101501), The Science and buy Staurosporine Technology Bureau of ShenZhen City grants(No.JC200903120125A), The Health Bureau of Guang Zhou City grants(No. 2009-YB-163), The Natural Science Foundation of ShenZhen University (No. 200921), The Natural Science Foundation of Guangzhou medical University (No.2008C06), the Laboratory Opening Grants of Shenzhen University(2011 year). References 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011,61(2):69–90.PubMedCrossRef 2. Lung Carcinoma: Tumors of the Lungs check details Merck
Manual Professional 2008., 2011: 3. Harley VR, Clarkson MJ, Argentaro A: The molecular action
and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. Endocr Rev 2003,24(4):466–487.PubMedCrossRef 4. Wagner T, Wirth MAPK inhibitor J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, et al.: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994,79(6):1111–1120.PubMedCrossRef 5. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, et al.: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related 3-mercaptopyruvate sulfurtransferase gene. Nature 1994,372(6506):525–530.PubMedCrossRef 6. Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, et al.: Upregulation of SOX9 in lung adenocarcinoma and its involvement
in the regulation of cell growth and tumorigenicity. Clin Cancer Res 2010,16(17):4363–4373.PubMedCrossRef 7. Muller P, Crofts JD, Newman BS, Bridgewater LC, Lin CY, Gustafsson JA, Strom A: SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res Treat 2010,120(2):317–326.PubMedCrossRef 8. Lu B, Fang Y, Xu J, Wang L, Xu F, Xu E, Huang Q, Lai M: Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 2008,130(6):897–904.PubMedCrossRef 9. Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, Balk SP, Yuan X: SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 2008,68(6):1625–1630.PubMedCrossRef 10. Ibrahim L, Dominguez M, Yacoub M: Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus. Immunology 1993,79(1):119–124.PubMed 11. American Joint Committee on Cancer. Cancer Staging Manual 7th edition. Springer; 2010. 12. Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M: Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 2008,14(21):6996–7003.PubMedCrossRef 13.